Revisión breve
Nuevos anticoagulantes orales en pacientes con enfermedad renal crónica
New oral anticoagulants in patients with chronic kidney disease
Lara Belmar Vega
, A.L.M. de Francisco, Jairo Bada da Silva, Luis Galván Espinoza, Gema Fernández Fresnedo
Autor para correspondencia
Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España
Leído
125537
Vecesse ha leído el artículo
11345
Total PDF
114192
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 295 | 45 | 340 |
| 2025 5 | 1458 | 87 | 1545 |
| 2025 4 | 1365 | 61 | 1426 |
| 2025 3 | 1506 | 81 | 1587 |
| 2025 2 | 1502 | 117 | 1619 |
| 2025 1 | 1423 | 72 | 1495 |
| 2024 12 | 1290 | 90 | 1380 |
| 2024 11 | 1498 | 88 | 1586 |
| 2024 10 | 1814 | 150 | 1964 |
| 2024 9 | 1626 | 90 | 1716 |
| 2024 8 | 1459 | 121 | 1580 |
| 2024 7 | 1674 | 134 | 1808 |
| 2024 6 | 1228 | 124 | 1352 |
| 2024 5 | 1494 | 108 | 1602 |
| 2024 4 | 1390 | 109 | 1499 |
| 2024 3 | 1442 | 109 | 1551 |
| 2024 2 | 1390 | 101 | 1491 |
| 2024 1 | 1771 | 105 | 1876 |
| 2023 12 | 1614 | 88 | 1702 |
| 2023 11 | 1665 | 148 | 1813 |
| 2023 10 | 1610 | 116 | 1726 |
| 2023 9 | 1638 | 129 | 1767 |
| 2023 8 | 1457 | 104 | 1561 |
| 2023 7 | 1595 | 148 | 1743 |
| 2023 6 | 1952 | 142 | 2094 |
| 2023 5 | 1918 | 116 | 2034 |
| 2023 4 | 1300 | 121 | 1421 |
| 2023 3 | 1590 | 125 | 1715 |
| 2023 2 | 1314 | 101 | 1415 |
| 2022 1 | 1139 | 109 | 1248 |
| 2022 12 | 938 | 111 | 1049 |
| 2022 11 | 1577 | 109 | 1686 |
| 2022 10 | 2355 | 124 | 2479 |
| 2022 9 | 2844 | 126 | 2970 |
| 2022 8 | 2140 | 110 | 2250 |
| 2022 7 | 1812 | 109 | 1921 |
| 2022 6 | 1678 | 135 | 1813 |
| 2022 5 | 1985 | 139 | 2124 |
| 2022 4 | 1674 | 128 | 1802 |
| 2022 3 | 2381 | 158 | 2539 |
| 2022 2 | 1673 | 138 | 1811 |
| 2021 1 | 1026 | 137 | 1163 |
| 2021 12 | 1022 | 101 | 1123 |
| 2021 11 | 1179 | 137 | 1316 |
| 2021 10 | 1371 | 170 | 1541 |
| 2021 9 | 1071 | 150 | 1221 |
| 2021 8 | 1130 | 173 | 1303 |
| 2021 7 | 1056 | 194 | 1250 |
| 2021 6 | 1140 | 158 | 1298 |
| 2021 5 | 1226 | 194 | 1420 |
| 2021 4 | 2315 | 323 | 2638 |
| 2021 3 | 1363 | 152 | 1515 |
| 2021 2 | 1354 | 129 | 1483 |
| 2020 1 | 1035 | 160 | 1195 |
| 2020 12 | 984 | 144 | 1128 |
| 2020 11 | 1301 | 143 | 1444 |
| 2020 10 | 1056 | 148 | 1204 |
| 2020 9 | 1043 | 157 | 1200 |
| 2020 8 | 1007 | 155 | 1162 |
| 2020 7 | 1078 | 130 | 1208 |
| 2020 6 | 1329 | 178 | 1507 |
| 2020 5 | 1156 | 209 | 1365 |
| 2020 4 | 1200 | 160 | 1360 |
| 2020 3 | 1167 | 174 | 1341 |
| 2020 2 | 1314 | 177 | 1491 |
| 2020 1 | 1139 | 160 | 1299 |
| 2019 12 | 1048 | 176 | 1224 |
| 2019 11 | 1590 | 175 | 1765 |
| 2019 10 | 1448 | 186 | 1634 |
| 2019 9 | 1364 | 196 | 1560 |
| 2019 8 | 1080 | 191 | 1271 |
| 2019 7 | 1334 | 236 | 1570 |
| 2019 6 | 1132 | 170 | 1302 |
| 2019 5 | 1176 | 208 | 1384 |
| 2019 4 | 1039 | 180 | 1219 |
| 2019 3 | 924 | 164 | 1088 |
| 2019 2 | 433 | 107 | 540 |
| 2019 1 | 404 | 126 | 530 |
| 2018 12 | 471 | 67 | 538 |
| 2018 11 | 874 | 27 | 901 |
| 2018 10 | 751 | 21 | 772 |
| 2018 9 | 290 | 27 | 317 |
| 2018 8 | 175 | 27 | 202 |
| 2018 7 | 142 | 21 | 163 |
| 2018 6 | 154 | 25 | 179 |
| 2018 5 | 175 | 20 | 195 |
| 2018 4 | 172 | 21 | 193 |
| 2018 3 | 118 | 14 | 132 |
| 2018 2 | 116 | 12 | 128 |
| 2018 1 | 106 | 12 | 118 |
| 2017 12 | 117 | 14 | 131 |
| 2017 11 | 128 | 22 | 150 |
| 2017 10 | 103 | 13 | 116 |
| 2017 9 | 140 | 20 | 160 |
| 2017 8 | 180 | 25 | 205 |
| 2017 7 | 408 | 26 | 434 |
| 2017 6 | 300 | 17 | 317 |
| 2017 5 | 214 | 11 | 225 |
| 2017 4 | 141 | 18 | 159 |
| 2017 3 | 119 | 8 | 127 |
| 2017 2 | 104 | 3 | 107 |
| 2016 1 | 92 | 10 | 102 |
| 2016 12 | 94 | 10 | 104 |
Mostrar todo
